Responses
Regular Abstracts – Part 2
Clinical Trial In Progress
782-C Regulatory T-cell tumor infiltration is associated to better outcome in advanced NSCLC patients under ≥2nd line anti-PD1/L1 monotherapy in the PIONeeR project
Compose a Response to This Article
Other responses
No responses have been published for this article.
